LeMaitre Vascular (LMAT) PT Lowered to $46 at Roth Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Roth Capital analyst Scott R. Henry lowered the price target on LeMaitre Vascular (NASDAQ: LMAT) to $46.00 (from $50.00) while maintaining a Neutral rating.
You May Also Be Interested In
- LeMaitre Vascular (LMAT) PT Lowered to $105 at Stifel
- Hut 8 Mining Corp. (HUT) PT Lowered to $120 at Craig-Hallum
- LeMaitre Vascular (LMAT) PT Lowered to $110 at Citizens on Slight EPS, EBITDA Misses
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
